Ziyue Fan
ABSTRACT
ERα plays an important role in breast tumor development and is regarded as an important target for breast cancer treatment. In order to assist the drug design for breast cancer target ERα, a machine learning method named Adaptive Boosting Extremely Random Tree (ABERT) is proposed in this paper, which is applied to construct the prediction model for the absorption, distribution, metabolism and excretion (ADME) of candidate compounds. Moreover, traditional machine learning and deep learning models are used to compare and reveal the advantages of our model. Besides, an external data set is used to verify the accuracy and stability of our model. The results show that our model has high accuracy in predicting ADME properties and can help to study the pharmacokinetics of candidate drugs as well as the Computer-Aided Drug Design (CADD) in early drug discovery for breast cancer.
- Huang, B., Omoto, Y., Iwase, H., 2014. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer. Proc Natl Acad Sci U S A 111, 1933-1938.Google Scholar
Cross Ref
- Zhang, X.T., Kang, L.G., Ding, L., 2011. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30, 770-780.Google ScholarCross Ref
- Ding, J., Wang, X., Zhang, Y., 2019. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα. Cancer Letters 440-441, 54-63.Google ScholarCross Ref
- Wong, C.H., Siah, K.W. AND Lo, A.W. 2018. Estimation of clinical trial success rates and related parameters. Biostatistics 20, 273-286.Google ScholarCross Ref
- Li, A.P. 2001. Screening for human ADME/Tox drug properties in drug discovery. Drug Discovery Today 6, 357-366.Google ScholarCross Ref
- Singh, S.S. 2006. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Current Drug Metabolism 7, 165-182.Google ScholarCross Ref
- Masimirembwa, C.M., Bredberg, U. AND Andersson, T.B. 2003. Metabolic Stability for Drug Discovery and Development: Pharmacokinetic and Biochemical Challenges. Clinical Pharmacokinetics 42, 515-543.Google ScholarCross Ref
- Kuppens, I.E.L.M., Breedveld, P., Beijnen, J.H., 2009. Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application. Cancer Investigation 23.Google Scholar
- Kaitin, K.I. 2008. Obstacles and opportunities in new drug development. Clinical Pharmacology & Therapeutics 83, 210-212.Google ScholarCross Ref
- Fuqiang, Ban, Kush, 2017. Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action. J.Chem.Inf.Model 57, 1018-1028.Google ScholarCross Ref
- Chuang, K.V., Gunsalus, L.M. AND Keiser, M.J. 2020. Learning Molecular Representations for Medicinal Chemistry. Journal of Medicinal Chemistry 63, 8705-8722.Google ScholarCross Ref
- Jie, D., Wang, N.N., Yao, Z.J., 2018. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. Journal of Cheminformatics 10, 29.Google ScholarCross Ref
- Pires, D., Blundell, T.L. AND Ascher, D.B. 2015. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry 58, 4066-4072.Google ScholarCross Ref
- Schneckener, S., Grimbs, S., Hey, J., 2019. Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters. Journal of Chemical Information and Modeling 59, 4893-4905.Google ScholarCross Ref
- Shi, T., Yang, Y., Huang, S., 2019. Molecular image-based convolutional neural network for the prediction of ADMET properties. Chemometrics and Intelligent Laboratory Systems 194, 103853.Google ScholarCross Ref
- Ma, J., Sheridan, R.P., Liaw, A., 2015. Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships. Journal of Chemical Information & Modeling 55, 263-274.Google ScholarCross Ref
- Yun, T., Liu, G., Li, W., 2013. In Silico ADMET Prediction: Recent Advances, Current Challenges and Future Trends. Current Topics in Medicinal Chemistry 13, 1273-1289.Google ScholarCross Ref
- Gleeson, M.P., Modi, S., Bender, A., 2012. The Challenges Involved in Modeling Toxicity Data In Silico: A Review. Current Pharmaceutical Design 18, 1266-1291.Google ScholarCross Ref
- Merlot, C. 2010. Computational toxicology—a tool for early safety evaluation. Drug Discovery Today 15, 16-22.Google ScholarCross Ref
- Jiang, D., Lei, T., Wang, Z., 2020. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning. Journal of Cheminformatics 12, 16.Google ScholarCross Ref
- Geurts, P., Ernst, D. AND Wehenkel, L. 2006. Extremely randomized trees. Machine Learning 63, 3-42.Google ScholarDigital Library
- Mitchell, T.M. 1997. Machine Learning. McGraw-Hill Education.Google ScholarDigital Library
Recommendations
Breast cancer drug toxicity prediction Based on AdaBoost Extremely Random Tree
BIC 2022: 2022 2nd International Conference on Bioinformatics and Intelligent ComputingEstrogen Receptor α (ERα) is considered as an important target for treating breast cancer, so compounds that can antagonize ERα may be candidate drugs for breast cancer. We predict the toxicities of candidate compounds by machine learning to achieve the ...
Insilico Docking Studies on Anticancer Drugs for Breast Cancer
IACSIT-SC '09: Proceedings of the 2009 International Association of Computer Science and Information Technology - Spring ConferenceCancer can be described as the uncontrolled growth of abnormal cells. Breast cancer is the second most common type of cancer after lung cancer. Normal breast cells and most breast cancer cells have receptors that attach to circulating estrogen and ...
Computer-aided detection of breast cancer on mammograms
PSOWNN - Particle Swarm Optimized Wavelet Neural Network. DB - Database.Display Omitted We propose a CAD system for detecting breast cancer in mammograms.Swarm intelligence optimized wavelet neural network detects the cancers.We focus on optimized ...
Comments